Burden of Gastrointestinal Disease in the United States: 2012 UpdateAnne F. Peery, Nicholas J. Shaheen, Hannah P. Kim et al.|Gastroenterology|2012Cited by 2k
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International RegistryErica J. Brenner, Michael D. Kappelman, Ryan C. Ungaro et al.|Gastroenterology|2020Cited by 692
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort studySubra Kugathasan, Marla C. Dubinsky, Lee A. Denson et al.|The Lancet|2017Cited by 647
Prevalence of Eosinophilic Esophagitis in the United StatesEvan S. Dellon, Michael D. Kappelman, Elizabeth T. Jensen et al.|Clinical Gastroenterology and Hepatology|2013Cited by 437
Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide studyMichael D. Kappelman, Henrik Toft Sørensen, Erzsébet Horváth–Puhó et al.|Gut|2011Cited by 301